Psychedelic Diaries episode summary:
We talk with Anthony Tennyson — CEO and cofounder of Awakn Life Sciences— about seeing psychedelics through four lenses: compound, therapy, therapist, and delivery.
— NUGGET AND A NOODLE: California city decriminalizes psychedelics; bringing the psychedelic industry together (0:44)
— Depression as inspiration to join psychedelic (3:01)
— How addiction changes your brain (10:25)
— Giving control back to the cognitive brain (13:29)
— Astounding clinical trial results (20:37)
— What would full legalization look like (24:01)
— SOUL SEARCH: desert island MDMA (26:56)
Anthony Tennyson is Chief Executive Officer at Awakn Life Sciences, a biotechnology company with clinical operations, developing and delivering psychedelic therapeutics (medicines
and therapies) to better treat addiction.
Anthony is an experienced financial services industry executive with 10 years in international strategy, commercial leadership roles with Aon plc, and 5 years with Merrill Lynch and Bank of Ireland. He holds an MBA in Strategy and Finance and an MSc in Technology, both from UCD, Ireland’s top ranked business school.
Find Anthony here: